- List
- By Topic
- On Map
- Search Details

7165009 [PUBMED-IDS]
Need help? See RSS Feeds
Choose a feed type:

7165009 [PUBMED-IDS] (19 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT01057589 | Completed Has Results |
A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
66 | All | 18 Years and older (Adult, Senior) | NCT01057589 | 12170 H3E-MC-S123 |
February 2010 | February 2012 | October 2012 | January 27, 2010 | September 18, 2013 | March 19, 2013 |
|
|
2 | NCT02442414 | Unknown † | A Phase 1 Study of KBP-5209 in Patients With Advanced Solid Tumors |
|
|
Interventional | Phase 1 |
|
Industry / Other |
|
|
30 | All | 18 Years and older (Adult, Senior) | NCT02442414 | 5209-CPK-1001 | April 2015 | August 2016 | December 2016 | May 13, 2015 | May 13, 2015 |
|
||
3 | NCT01387204 | Completed | Study to Investigate the Absorption, Distribution, Metabolism and Elimination of [14C]GSK1120212 |
|
|
Interventional | Phase 1 |
|
Industry |
|
|
6 | Male | 18 Years and older (Adult, Senior) | NCT01387204 | 113708 | February 15, 2011 | July 18, 2011 | July 18, 2011 | July 4, 2011 | November 13, 2017 |
|
||
4 | NCT01166529 | Withdrawn | Endoscopic Ultrasound-guided Celiac Plexus Neurolysis in the Management of Pain in Abdominal Non-pancreatic Malignancies |
|
|
Interventional | Not Applicable |
|
Other |
|
|
0 | All | 18 Years and older (Adult, Senior) | NCT01166529 | NU protocol #0917 (eIRB 20311) | August 2010 | July 2013 | July 2013 | July 21, 2010 | September 25, 2014 |
|
||
5 | NCT03482570 | Recruiting New |
Activity Behaviours in Patients With Malignant Pleural Effusion |
|
|
Observational |
|
Other |
|
|
200 | All | 18 Years and older (Adult, Senior) | NCT03482570 | HKU_UW_17_516 | January 31, 2018 | December 31, 2019 | December 31, 2020 | March 29, 2018 | April 2, 2018 |
|
|||
6 | NCT03371992 | Enrolling by invitation | Pilot Study of Nilogen 3D-EX and Its Ability to Predict Therapeutic Response to Anti-PD1 or Anti-PDL1 in NSCLC |
|
|
Interventional | Early Phase 1 |
|
Industry / Other |
|
|
25 | All | 18 Years and older (Adult, Senior) | NCT03371992 | NO88352235 | NO3DEXPL | March 9, 2018 | August 2018 | August 2018 | December 13, 2017 | April 5, 2018 |
|
|
7 | NCT03103724 | Recruiting | A Phase II Study Evaluating the Efficacy of Enzalutamide and the Role of ARv7 in Metastatic Castration Resistant Prostate Cancer (mCRPC) Patients With Visceral Disease. |
|
|
Interventional | Phase 2 |
|
Other |
|
|
68 | Male | 18 Years and older (Adult, Senior) | NCT03103724 | INT 178-15 | EXCALIBUR | March 16, 2017 | March 16, 2019 | March 16, 2019 | April 6, 2017 | April 24, 2017 |
|
|
8 | NCT02628379 | Completed | Outcomes of FoundationOne Directed Therapy in Cancer of Unknown Primary |
|
Observational |
|
Industry / Other |
|
|
500 | All | 18 Years and older (Adult, Senior) | NCT02628379 | RAP-CLT-15-010 | May 2015 | March 2017 | December 11, 2015 | April 12, 2017 |
|
|||||
9 | NCT02583516 | Active, not recruiting | Clinical Trial to Evaluate the Efficacy of Vemurafenib in Combination With Cobimetinib (Continuous and Intermittent) in BRAFV600-mutation Positive Patients With Unresectable Locally Advanced or Metastatic Melanoma |
|
|
Interventional | Phase 2 |
|
Other / Industry |
|
|
70 | All | 18 Years and older (Adult, Senior) | NCT02583516 | GEM-01-15 2014-005277-36 |
June 30, 2015 | September 2019 | September 2019 | October 22, 2015 | February 16, 2018 |
|
||
10 | NCT02495376 | Completed | Reducing Emotional Distress, Enhancing Function and Improving Network Engagement in Adolescent and Young Adult Oncology |
|
|
Interventional | Not Applicable |
|
Other |
|
|
151 | All | 18 Years to 39 Years (Adult) | NCT02495376 | STU00093614 | REDEFINEAYAO | June 2014 | December 2017 | December 2017 | July 13, 2015 | April 18, 2018 |
|
|
11 | NCT02448589 | Recruiting | An Investigation of TAS-119 Monotherapy and in Combination With Docetaxel |
|
|
Interventional | Phase 1 |
|
Industry |
|
|
80 | All | 18 Years and older (Adult, Senior) | NCT02448589 | TAS-119-102 2014-001272-63 |
September 2014 | March 2017 | October 2017 | May 19, 2015 | September 27, 2016 |
|
||
12 | NCT02439112 | Recruiting | Exercise in Patients With Multiple Myeloma |
|
|
Interventional | Not Applicable |
|
Other |
|
|
88 | All | 18 Years and older (Adult, Senior) | NCT02439112 | Reum,fys/ergo 1 | EMMY | May 2015 | March 2017 | December 2017 | May 8, 2015 | January 26, 2017 |
|
|
13 | NCT02272816 | Active, not recruiting | Carboplatin AUC-10 for Metastatic Seminoma With IGCCCG Good Prognosis Disease-Therapy Directed by Initial Metabolic Response on PET-CT |
|
|
Interventional | Phase 2 |
|
Other |
|
|
48 | Male | 18 Years to 75 Years (Adult, Senior) | NCT02272816 | 007065 2009-009882-33 |
Car-PET | February 2012 | December 2017 | December 2017 | October 23, 2014 | August 31, 2017 |
|
|
14 | NCT02186015 | Active, not recruiting | Safety, Feasibility and Efficacy of Vitamin D Supplementation in Women With Metastatic Breast Cancer (SAFE-D) |
|
|
Interventional | Phase 1 |
|
Other |
|
|
11 | Female | 18 Years and older (Adult, Senior) | NCT02186015 | 206519 | SAFE-D | February 2015 | October 2017 | June 2018 | July 10, 2014 | November 22, 2017 |
|
|
15 | NCT02185690 | Recruiting | A Phase I/Ib Study of MEK162, a MEK Inhibitor, in Combination With Carboplatin and Pemetrexed in Patients With Non-squamous Carcinoma of the Lung |
|
|
Interventional | Phase 1 |
|
Other / Industry |
|
|
30 | All | 18 Years to 90 Years (Adult, Senior) | NCT02185690 | CMEK162BCA01T | MEK162 | January 11, 2018 | March 2019 | April 2019 | July 9, 2014 | February 5, 2018 |
|
|
16 | NCT01894321 | Completed | The Clinical Outcomes of the Percutaneous Cholecystostomy, Supportive Care Versus Cholecystectomy. |
|
Observational |
|
Other |
|
|
82 | All | Child, Adult, Senior | NCT01894321 | PTGBD1 | January 2007 | December 2012 | December 2012 | July 10, 2013 | July 10, 2013 |
|
||||
17 | NCT01791387 | Unknown † | 1st-line Activity of Dovitinib and Correlation With Genetic Changes in RCC |
|
|
Interventional | Phase 2 |
|
Other / Industry |
|
|
30 | All | 18 Years and older (Adult, Senior) | NCT01791387 | CTKI258AAU02T ACTRN12612000140853 |
DILIGENCE-1 | March 2012 | June 2015 | June 2015 | February 15, 2013 | February 3, 2015 |
|
|
18 | NCT01779219 | Terminated Has Results |
Intraoperative MRI-guidance in Frameless Stereotactic Biopsies |
|
|
Interventional | Not Applicable |
|
Other |
|
|
42 | All | 18 Years and older (Adult, Senior) | NCT01779219 | STAT2009 | June 2009 | October 2015 | October 2015 | January 30, 2013 | February 15, 2016 | February 15, 2016 |
|
|
19 | NCT01053884 | Terminated | Anidulafungin in Patients With Hematologic Malignancies |
|
|
Interventional | Phase 2 |
|
Other / Industry |
|
|
10 | All | 18 Years and older (Adult, Senior) | NCT01053884 | Anidulafungin - MG-ECALTA1 2009-014527-23 |
ECALTA | October 2009 | September 2011 | September 2011 | January 22, 2010 | March 2, 2012 |
|
† Study has passed its completion date and status has not been verified in more than two years.